These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28858970)
61. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293 [TBL] [Abstract][Full Text] [Related]
62. Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients. Velikova N; Wells JM Curr Drug Targets; 2017; 18(6):687-695. PubMed ID: 26853320 [TBL] [Abstract][Full Text] [Related]
63. The approach to Pseudomonas aeruginosa in cystic fibrosis. Bendiak GN; Ratjen F Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546 [TBL] [Abstract][Full Text] [Related]
64. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788 [TBL] [Abstract][Full Text] [Related]
66. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Aris RM; Gilligan PH; Neuringer IP; Gott KK; Rea J; Yankaskas JR Am J Respir Crit Care Med; 1997 May; 155(5):1699-704. PubMed ID: 9154879 [TBL] [Abstract][Full Text] [Related]
67. Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study. Deppisch C; Herrmann G; Graepler-Mainka U; Wirtz H; Heyder S; Engel C; Marschal M; Miller CC; Riethmüller J Infection; 2016 Aug; 44(4):513-20. PubMed ID: 26861246 [TBL] [Abstract][Full Text] [Related]
68. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance]. Coman G; Petraru E; Dahorea C; Anton DT Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957 [TBL] [Abstract][Full Text] [Related]
69. The Impact of Resistant Bacterial Pathogens including Pseudomonas aeruginosa and Burkholderia on Lung Transplant Outcomes. Mitchell AB; Glanville AR Semin Respir Crit Care Med; 2021 Jun; 42(3):436-448. PubMed ID: 34030205 [No Abstract] [Full Text] [Related]
70. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Meachery G; De Soyza A; Nicholson A; Parry G; Hasan A; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA Thorax; 2008 Aug; 63(8):725-31. PubMed ID: 18487317 [TBL] [Abstract][Full Text] [Related]
71. Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus model. Le Moigne V; Rottman M; Goulard C; Barteau B; Poncin I; Soismier N; Canaan S; Pitard B; Gaillard JL; Herrmann JL Vaccine; 2015 Apr; 33(18):2118-24. PubMed ID: 25804706 [TBL] [Abstract][Full Text] [Related]
77. Lung transplantation for cystic fibrosis: differential characteristics and outcomes between children and adults. Moreno P; Alvarez A; Carrasco G; Redel J; Guaman HD; Baamonde C; Algar FJ; Cerezo F; Salvatierra A Eur J Cardiothorac Surg; 2016 May; 49(5):1334-43. PubMed ID: 26530270 [TBL] [Abstract][Full Text] [Related]
78. Aerosolized vancomycin for the treatment of MRSA after lung transplantation. Hayes D; Murphy BS; Mullett TW; Feola DJ Respirology; 2010 Jan; 15(1):184-6. PubMed ID: 19895389 [TBL] [Abstract][Full Text] [Related]
79. Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis. Burcham P; Sarzynski L; Khalfoun S; Novak KJ; Miller JC; Tumin D; Hayes D Paediatr Drugs; 2017 Aug; 19(4):339-346. PubMed ID: 28547678 [TBL] [Abstract][Full Text] [Related]